Insys Sets Aside $4.5M For Settlement Of Illinois’ Opioid Off-Label Lawsuit
PHOENIX — Insys Therapeutics Inc. on Aug. 3 announced that it has taken a $4.5 million charge for a potential settlement of Illinois’ consumer fraud lawsuit over the drug company’s alleged...To view the full article, register now.
Already a subscriber? Click here to view full article